Evinacumab for the treatment of homozygous familial hypercholesterolaemia: first patient case report in Switzerland

Evinacumab for the treatment of homozygous familial hypercholesterolaemia: first patient case report in Switzerland

We present the first case in Switzerland of a patient with homozygous familial hypercholesterolaemia treated with evinacumab, a new recombinant human monoclonal antibody currently approved in Europe and in the USA but not yet in Switzerland. Homozygous familial hypercholesterolaemia is a rare genet...

Full description

Saved in:

Bibliographic Details
Main Authors:	Noé Corpataux, Fabienne Aregger, Konstantinos C. Koskinas, Catherine Gebhard
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2025-02-01
Series:	Swiss Medical Weekly
Online Access:	https://smw.ch/index.php/smw/article/view/4024
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Lomitapide modifies high-density lipoprotein function in homozygous familial hypercholesterolaemia
by: Anouar Hafiane, et al.
Published: (2025-04-01)

Outpatient monthly plasmapheresis with post-PLEX evinacumab in pediatric homozygous familial hypercholesterolemia: a case report on port access and immunoglobulin preservation
by: Guido Filler, et al.
Published: (2025-07-01)

Familial hypercholesterolaemia
by: D.J. Blom
Published: (2011-01-01)

Inclisiran for the treatment of hypercholesterolaemia
by: Joel C Marrs, et al.
Published: (2024-11-01)

Hokuriku-plus familial hypercholesterolaemia registry study: rationale and study design
by: Hiroshi Matsumoto, et al.
Published: (2020-09-01)

Effects of Inclisiran, Alirocumab, Evolocumab, and Evinacumab on Lipids: A Network Meta-Analysis
by: Lin Zhang, et al.
Published: (2025-02-01)

Evolocumab-induced delayed skin hypersensitivity reaction in a patient with familial hypercholesterolaemia
by: Grzegorz Porebski, et al.
Published: (2024-02-01)

Hypercholesterolaemia in children and young adults — current management
by: Frederick Raal
Published: (2008-02-01)

Cost-effectiveness of evolocumab in treatment of heterozygous familial hypercholesterolaemia in Bulgaria: measuring health benefit by effectively treated patient-years*
by: Borislav Borissov, et al.
Published: (2017-01-01)

Efficacy of a novel PCSK9 inhibitory peptide alone and with evinacumab in a mouse model of atherosclerosis
by: José A. Inia, et al.
Published: (2025-03-01)

Paradox of hypercholesterolaemia in highly trained, keto-adapted athletes
by: Brent C Creighton, et al.
Published: (2018-12-01)

Process for mainstreaming genetic cascade testing into primary and tertiary health systems in familial hypercholesterolaemia (FH), an autosomal dominant, fully penetrant disorder
by: Bridie Carr, et al.
Published: (2025-08-01)

Diagnosis and Screening Strategies for Detection of Familial Hypercholesterolaemia in Children and Adolescents in Italy: A Survey from the LIPIGEN Paediatric Group
by: Cristina Pederiva, et al.
Published: (2025-02-01)

Screening for familial hypercholesterolaemia in primary school children: protocol for a cross-sectional, feasibility study in Luxembourg city (EARLIE)
by: Valéry Bocquet, et al.
Published: (2022-12-01)

Homozygous Familial Hypercholesterolemia: Case Series and Review of the Literature
by: Carlos H. Palacio, et al.
Published: (2011-01-01)

Familial hypercholesterolaemia with early-onset coronary artery disease and recurrent in-stent restenosis associated with the LDLR gene c.428G>A mutation: a case report
by: Chengpeng Zhang, et al.
Published: (2025-06-01)

Implementation of a primary-tertiary shared care model to improve the detection of familial hypercholesterolaemia (FH): a mixed methods pre-post implementation study protocol
by: David Sullivan, et al.
Published: (2024-05-01)

PCSK9 targeting therapies for familial hypercholesterolaemia: a meta-analysis of efficacy on lipid biomarkers and safety in adults and children across 23 RCTs
by: Vinh Q T Ho, et al.
Published: (2025-08-01)

Familial homozygous hypercholesterolemia with arcus cornea and xanthomas: A rare but serious entity
by: Amal Chamli, et al.
Published: (2023-03-01)

Family planning, pregnancy, and breastfeeding care in familial hypercholesterolaemia: a study protocol for a mixed-methods study in the Netherlands, Norway and Australia (Taking ACTion to Improve Care of coupleS in FH (TACTICS))
by: Eric Boersma, et al.
Published: (2025-03-01)

Beyond the homozygous paradigm: symptomatic partial biotinidase deficiency in a heterozygous child—first case report from Nepal
by: Jagdish Kunwar, et al.
Published: (2025-06-01)

Severe bronchiectasis and chronic rhinosinusitis due to homozygous WFDC2 Variants: The first three cases reported from Japan
by: Masashi Ito, et al.
Published: (2025-01-01)

Liver transplantation for homozygous familial hypercholesterolemia: a retrospective analysis from Chinese experience
by: Hao-Su Zhan, et al.
Published: (2025-01-01)

Homozygous Familial Hypobetalipoproteinemia Diagnosed in Adulthood With a New Splicing Variant of the APOB Gene
by: Alyssa Sim, et al.
Published: (2022-08-01)

The effectiveness of liver transplantation in reducing lipid levels in Saudi children with homozygous familial hypercholesterolemia
by: Abdullah Al-Ashwal, et al.
Published: (2024-11-01)

Characterisation and Hypolipidaemic Effects of Tlayudas, Widely Consumed Tortillas, Containing Ganoderma lucidum Extracts on an In Vivo Model of Hypercholesterolaemia
by: Grace Preciado Iñiga, et al.
Published: (2025-01-01)

Assessing the prevalence of obesity in a Russian adult population by six indices and their associations with hypertension, diabetes mellitus and hypercholesterolaemia
by: Kamila Kholmatova, et al.
Published: (2024-12-01)

A “Weak” Reflection on Unpredictability and Social Theory
by: Charalambos Tsekeris, et al.
Published: (2010-03-01)

Competency-based education – the reform of postgraduate medical training in Switzerland
by: Schwitz, Fabienne, et al.
Published: (2024-11-01)

A novel homozygous mutation identified by whole exome sequencing in a consanguineous family with metachromatic leukodystrophy: a case report
by: Xueyi Li, et al.
Published: (2024-11-01)

Correction to: Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights from the CASCADE FH Registry
Published: (2023-06-01)

Tracing the Sars-CoV-2 Impact: The First Month in Switzerland
by: Joseph Molloy, et al.
Published: (2020-05-01)

Rheumatoid-like hand deformities and aortic valve disease in a 13-year-old girl with homozygous familial hypercholesterolemia: a case report
by: Anjuman Ara Rahman, et al.
Published: (2025-02-01)

Homozygous familial hypercholesterolemia: case report of a rare cause of dyslipidemia Homozygotyczna rodzinna hipercholesterolemia. Opis przypadku dotyczący rzadkich przyczyn dyslipidemii
by: Cresio Alves, et al.
Published: (2011-09-01)

New insights into the management of homozygous familial hypercholesterolemia patients treated with lomitapide: a single-center experience
by: Gabriella Iannuzzo, et al.
Published: (2024-12-01)

Effects of artificial intelligence-SsupporTed Automated NutRiTional Intervention on LDL cholesterol Control in Patients with Familial Hypercholesterolaemia (iSTART-FH): protocol for a randomised controlled trial
by: Akihiro Nomura, et al.
Published: (2021-12-01)

Family Medicine Practice as Learning Environment: A Medical Student Evaluation in Switzerland
by: Di Gangi S, et al.
Published: (2024-12-01)

SCIENCEINDUSTRIES Switzerland
by: David Spichiger
Published: (2024-12-01)

First Single-Centre Experience with the Novel HIF-α Inhibitor Belzutifan in Switzerland
by: Tobias Peres, et al.
Published: (2025-01-01)

Isogenic induced pluripotent stem cell line ICGi036-A-1 from a patient with familial hypercholesterolaemia, derived by correcting a pathogenic variant of the gene LDLR c.530C>T
by: A. S. Zueva, et al.
Published: (2025-04-01)